Yeast DEL assay detects clastogens

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 582, Issue 1-2, 2005, Pages 116-134

  Kirpnick, Zhanna ^a   Homiski, Michael ^b   Rubitski, Elizabeth ^b   Repnevskaya, Marina ^a   Howlett, Niall ^c   Aubrecht, Jiri ^b   Schiestl, Robert H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Clastogens; DNA deletions; Genotoxicity; Short term assay

Indexed keywords

ACRIDINE; ACRYLIC ACID METHYL ESTER; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CLASTOGEN; DACTINOMYCIN; DIMPYLATE; DOUBLE STRANDED DNA; FLOXURIDINE; FUROSEMIDE; INDUSTRIAL CHEMICAL; INSECTICIDE; METHOTREXATE; NOSCAPINE; RESORCINOL;

ANIMAL CELL; ARTICLE; ASSAY; CELL WALL; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; DELETION ASSAY; DIFFUSION; DNA STRAND BREAKAGE; GENE DELETION; GENOTOXICITY; IN VITRO STUDY; INTERMETHOD COMPARISON; LIPOPHILICITY; LIVER; METABOLIC ACTIVATION; MICRONUCLEUS TEST; MODEL; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; STANDARD; TOXICITY TESTING; YEAST; YEAST CELL;

SACCHAROMYCES CEREVISIAE; SALMONELLA;

EID: 15244350114     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2005.01.005     Document Type: Article

References (68)

1. J.A. DiMasi Success rates for new drugs entering clinical testing in the United States Clin. Pharmacol. Ther. 58 1995 1 14
2. F. Mitelman Catalog of Chromosome Aberrations in Cancer 1991 Wiley-Liss New York
3. L. Muller, Y. Kikuchi, G. Probst, L. Schechtman, H. Shimada, T. Sofuni, and D. Tweats ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact Mutat. Res. 436 1999 195 225
4. H.J. Evans, and M.L. O'Riordan Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests Mutat. Res. 31 1975 135 148
5. D. Clive, K.O. Johnson, J.F. Spector, A.G. Batson, and M.M. Brown Validation and characterization of the L5178Y/TK ± mouse lymphoma mutagen assay system Mutat. Res. 59 1979 61 108
6. S.M. Galloway, M.J. Aardema, M. Ishidate, Jr., J.L. Ivett, D.J. Kirkland, T. Morita, P. Mosesso, T. Sofuni, Report from Working Group on In Vitro Tests for Chromosomal Aberrations, Mutat. Res. 312 (1994) pp. 241-261.
7. J. Cole, K. Harrington-Brock, and M.M. Moore The mouse lymphoma assay in the wake of ICH4 - where are we now? Mutagenesis 14 1999 265 270
8. J. Cole, C.F. Arlett, M.H. Green, J. Lowe, and W. Muriel A comparison of the agar cloning and microtitration techniques for assaying cell survival and mutation frequency in L5178Y mouse lymphoma cells Mutat. Res. 111 1983 371 386
9. B. Miller, F. Potter-Locher, A. Seelbach, H. Stopper, D. Utesch, and S. Madle Evaluation of the in vitro micronucleus test as an alternative to the in vitro chromosomal aberration assay: position of the GUM Working Group on the in vitro micronucleus test. Gesellschaft fur Umwelt-Mutations-forschung Mutat. Res. 410 1998 81 116
10. S. Vamvakas, E.H. Vock, and W.K. Lutz On the role of DNA double-strand breaks in toxicity and carcinogenesis Crit. Rev. Toxicol. 27 1997 155 174
11. K.K. Khanna, and S.P. Jackson DNA double-strand breaks: signaling, repair and the cancer connection Nat. Genet. 27 2001 247 254
12. M. Fenech, and A.A. Morley Measurement of micronuclei in lymphocytes Mutat. Res. 147 1985 29 36
13. H. Stopper, and S.O. Muller Micronuclei as a Biological Endpoint for Genotoxicity: a minireview Toxicol. in vitro 11 1997 661 667
14. M. Fenech The in vitro micronucleus technique Mutat. Res. 455 2000 81 95
15. D.A. Eastmond, and J.D. Tucker Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an antikinetochore antibody Environ. Mol. Mutagen. 13 1989 34 43
16. P. Smolewski, Q. Ruan, L. Vellon, and Z. Darzynkiewicz Micronuclei assay by laser scanning cytometry Cytometry 45 2001 19 26
17. D. Roman, F. Locher, W. Suter, A. Cordier, and M. Bobadilla Evaluation of a new procedure for the flow cytometric analysis of in vitro, chemically induced micronuclei in V79 cells Environ. Mol. Mutagen. 32 1998 387 396
18. R.H. Schiestl, S. Igarashi, and P.J. Hastings Analysis of the mechanism for reversion of a disrupted gene Genetics 119 1988 237 247
19. R.H. Schiestl, R.D. Gietz, R.D. Mehta, and P.J. Hastings Carcinogens induce intrachromosomal recombination in yeast Carcinogenesis 10 1989 1445 1455
20. R.H. Schiestl Nonmutagenic carcinogens induce intrachromosomal recombination in yeast Nature 337 1989 285 288
21. N. Carls, and R.H. Schiestl Evaluation of the yeast DEL assay with 10 compounds selected by the International Program on chemical safety for the evaluation of short-term tests for carcinogens Mutat. Res. 320 1994 293 303
22. R.J. Brennan, and R.H. Schiestl Detecting carcinogens with the yeast DEL assay Methods Mol. Biol. 262 2004 111 124
23. A. Galli, and R.H. Schiestl On the mechanism of UV and gamma-ray-induced intrachromosomal recombination in yeast cells synchronized in different stages of the cell cycle Mol. Gen. Genet. 248 1995 301 310
24. A. Galli, and R.H. Schiestl Effects of Salmonella assay negative and positive carcinogens on intrachromosomal recombination in G1-arrested yeast cells Mutat. Res. 370 1996 209 221
25. J. Aubrecht, R.K. Narla, P. Ghosh, J. Stanek, and F.M. Uckun Molecular genotoxicity profiles of apoptosis-inducing vanadocene complexes Toxicol. Appl. Pharmacol. 154 1999 228 235
26. D. Maron, J. Katzenellenbogen, and B.N. Ames Compatibility of organic solvents with the salmonella/microsome test Mutat. Res. 88 1981 343 350
27. N.G. Howlett, and R.H. Schiestl Nucleotide excision repair deficiency causes elevated levels of chromosome gain in Saccharomyces cerevisiae DNA Repair (Amst) 3 2004 127 134
28. N.G. Howlett, and R.H. Schiestl Simultaneous measurement of the frequencies of intrachromosomal recombination and chromosome gain using the yeast DEL assay Mutat. Res. 454 2000 53 62
29. N. Page, M. Gerard-Vincent, P. Menard, M. Beaulieu, M. Azuma, G.J. Dijkgraaf, H. Li, J. Marcoux, T. Nguyen, T. Dowse, A.M. Sdicu, and H. Bussey A Saccharomyces cerevisiae genome-wide mutant screen for altered sensitivity to K1 killer toxin Genetics 163 2003 875 894
30. B.N. Ames, F.D. Lee, and W.E. Durston An improved bacterial test system for the detection and classification of mutagens and carcinogens Proc. Natl. Acad. Sci. U.S.A. 70 1973 782 786
31. E. Balzi, and A. Goffeau Yeast multidrug resistance: the PDR network J. Bioenerg. Biomembr. 27 1995 71 76
32. M. Schmitt, G. Gellert, J. Ludwig, and H. Lichtenberg-Frate Phenotypic yeast growth analysis for chronic toxicity testing Ecotoxicol. Environ. Saf. 59 2004 142 150
33. R.J. Reid, E.A. Kauh, and M.A. Bjornsti Camptothecin sensitivity is mediated by the pleiotropic drug resistance network in yeast J. Biol. Chem. 272 1997 12091 12099
34. J. Aubrecht, R. Rugo, and R.H. Schiestl Carcinogens induce intrachromosomal recombination in human cells Carcinogenesis 16 1995 2841 2846
35. N. Yajima, K. Kondo, and K. Morita Reverse mutation tests in Salmonella typhimurium and chromosomal aberration tests in mammalian cells in culture on fluorinated pyrimidine derivatives Mutat. Res. 88 1981 241 254
36. A. Galli, and R.H. Schiestl Effects of DNA double-strand and single-strand breaks on intrachromosomal recombination events in cell-cycle-arrested yeast cells Genetics 149 1998 1235 1250
37. A.J. Bishop, and R.H. Schiestl Role of homologous recombination in carcinogenesis Exp. Mol. Pathol. 74 2003 94 105
38. J.D. Tucker, and R.J. Preston Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges, and cancer risk assessment Mutat. Res. 365 1996 147 159
39. L.R. Ferguson, and W.A. Denny The genetic toxicology of acridines Mutat. Res. 258 1991 123 160
40. L.S. Lerman, DNA. Acridine Mutagens, and Structure J. Cell Physiol. 64 Suppl. 1 1964 1 18
41. G.M. Seixas, B.M. Andon, P.G. Hollingshead, and W.G. Thilly The aza-arenes as mutagens for Salmonella typhimurium Mutat. Res. 102 1982 201 212
42. J.B. Phelps, M.L. Garriott, and W.P. Hoffman A protocol for the in vitro micronucleus test. II. Contributions to the validation of a protocol suitable for regulatory submissions from an examination of 10 chemicals with different mechanisms of action and different levels of activity Mutat. Res. 521 2002 103 112
43. A. Matsuoka, K. Shudo, Y. Saito, T. Sofuni, and M. Ishidate Jr. Clastogenic potential of heavy oil extracts and some aza-arenes in Chinese hamster cells in culture Mutat. Res. 102 1982 275 283
44. B.A. Chabner, D.P. Ryan, L. Paz-Ares, R. Garcia-Carbonero, and P. Calabresi Antineoplastic agents J.G. Hardman L.E. Limbird Goodman & Gilman's The Pharmacological Basis of Therapeutics 2001 McGraw-Hill New York pp. 1389-1459
45. W.F. Benedict, M.S. Baker, L. Haroun, E. Choi, and B.N. Ames Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome test Cancer Res. 37 1977 2209 2213
46. W.R. Wilson, N.M. Harris, and L.R. Ferguson Comparison of the mutagenic and clastogenic activity of amsacrine and other DNA-intercalating drugs in cultured V79 Chinese hamster cells Cancer Res. 44 1984 4420 4431
47. M.L. Garriott, J.B. Phelps, and W.P. Hoffman A protocol for the in vitro micronucleus test. I. Contributions to the development of a protocol suitable for regulatory submissions from an examination of 16 chemicals with different mechanisms of action and different levels of activity Mutat. Res. 517 2002 123 134
48. L.C. Backer, J.W. Allen, K. Harrington-Brock, J.A. Campbell, D.M. DeMarini, C.L. Doerr, D.R. Howard, A.D. Kligerman, and M.M. Moore Genotoxicity of inhibitors of DNA topoisomerases I (camptothecin) and II (m-AMSA) in vivo and in vitro Mutagenesis 5 1990 541 547
49. F. Degrassi, R. De Salvia, C. Tanzarella, and F. Palitti Induction of chromosomal aberrations and SCE by camptothecin, an inhibitor of mammalian topoisomerase I Mutat. Res. 211 1989 125 130
50. T.C. Marshall, H.W. Dorough, and H.E. Swim Screening of pesticides for mutagenic potential using Salmonella typhimurium mutants J. Agric. Food Chem. 24 1976 560 563
51. Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological profile for diazinon, U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA (1996) 92-94.
52. E.K. Jackson Diuretics J.G. Hardman L.E. Limbird Goodman & Gilman's The Pharmacological Basis of Therapeutics 2001 McGraw-Hill New York 769 773
53. E. Zeiger, B. Anderson, S. Haworth, T. Lawlor, K. Mortelmans, and W. Speck Salmonella mutagenicity tests: III. results from the testing of 255 chemicals Environ. Mutagen 9 1987 1 109
54. Furosemide (frusemide), IARC Monogr Eval Carcinog Risks Hum 50 (1990) 277-291.
55. DHHS/NTP, Toxicology and Carcinogenesis studies of furosemide in F344/N rats and B6C3F1 mice (feed studies), in: Technical Report Series No. 356 NIH Pub No. 89-2811, NIH, 1989.
56. Methyl acrylate, IARC Monogr Eval Carcinog Risks Hum 71 (Pt 3) (1999) 1489-1496.
57. K.L. Dearfield, K. Harrington-Brock, C.L. Doerr, J.R. Rabinowitz, and M.M. Moore Genotoxicity in mouse lymphoma cells of chemicals capable of Michael addition Mutagenesis 6 1991 519 525
58. M.M. Moore, A. Amtower, C.L. Doerr, K.H. Brock, and K.L. Dearfield Genotoxicity of acrylic acid, methyl acrylate, ethyl acrylate, methyl methacrylate, and ethyl methacrylate in L5178Y mouse lymphoma cells Environ. Mol. Mutagen 11 1988 49 63
59. C. Keshava, N. Keshava, W.Z. Whong, J. Nath, and T.M. Ong Inhibition of methotrexate-induced chromosomal damage by folinic acid in V79 cells Mutat. Res. 397 1998 221 228
60. C. Mondello, R. Giorgi, and F. Nuzzo Chromosomal effects of methotrexate on cultured human lymphocytes Mutat. Res. 139 1984 67 70
61. H.B. Gutstein, and H. Akil Opioid analgesics J.G. Hardman L.E. Limbird Goodman & Gilman's The Pharmacological Basis of Therapeutics 2001 McGraw-Hill New York 569 619
62. M. Schuler, P. Muehlbauer, P. Guzzie, and D.A. Eastmond Noscapine hydrochloride disrupts the mitotic spindle in mammalian cells and induces aneuploidy as well as polyploidy in cultured human lymphocytes Mutagenesis 14 1999 51 56
63. D.G. Gatehouse, G. Stemp, S. Pascoe, P. Wilcox, J. Hawker, and D.J. Tweats Investigations into the induction of aneuploidy and polyploidy in mammalian cells by the anti-tussive agent noscapine hydrochloride Mutagenesis 6 1991 279 283
64. M. Ishidate Jr., M.C. Harnois, and T. Sofuni A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures Mutat. Res. 195 1988 151 213
65. Resorcinol, IARC Monogr Eval Carcinog Risks Hum 71 (Pt 3) (1999) 1119-1131.
66. M.M. Shahin, A. Bugaut, P. Gilard, and G. Kalopissis Studies on the mutagenicity of resorcinol and hydroxy-3-(p-amino)anilino-6,N-[(p-amino)phenol] benzoquinone-monoimine-1,4 in Salmonella typhimurium Mutat. Res. 78 1980 213 218
67. F. Darroudi, and A.T. Natarajan Cytogenetic analysis of human peripheral blood lymphocytes (in vitro) treated with resorcinol Mutat. Res. 124 1983 179 189
68. V.F. Simmon In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium J. Natl. Cancer Inst. 62 1979 893 899